Amarin Still Suspends FY22 Guidance On Generic Challenges
Amarin Corporation plc (NASDAQ:AMRN) continues suspending 2022 revenue guidance citing the ongoing global impact of COVID-19, the uncertainty resulting from the…
Brink’s (BCO) Tops Q2 Earnings And Revenue Estimates
Brink's (NYSE: BCO) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.18 per share a year ago. These figures are adjusted for non-recurring items.
Dow Jumps 350 Points; Crude Oil Drops Over 2%
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 350 points on Wednesday.
Merrimack Pharma-Ipsen’s Cancer Drug Fails In Overall Survival Measure
Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) partner announced that Ipsen SA (OTC:IPSEY) reported a primary analysis of the results of the…
OIIM: Inventory Corrections for Battery Management Products Are Expected to Affect Q3 2022
By Lisa Thompson
NASDAQ:OIIM
READ THE FULL OIIM RESEARCH REPORT
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
Short Interest Sector Focus: Technology Sector
As of the close of business on Tuesday, 8/2, we captured the Top 10 Highest Short Interest % stocks within the Technology Sector.
The average short interest for stocks within the Technology sector stands at 3.64%. Therefore, the below stocks are showing a more pessimistic outlook than their peers within the respective sector.
Short Volatility Alert: Applied DNA Sciences, Inc.
On Tuesday, shares of Applied DNA Sciences, Inc. (NASDAQ: APDN) experienced volatile short activity. After the activity, the stock price went up +296.94% to $2.80.
The overall sentiment for APDN has been Bearish.
Why Upstart And Other Lending Stocks Are Catching Bids Today
Upstart Holdings Inc (NASDAQ: UPST) shares are trading higher Wednesday, in sympathy with SoFi Technologies Inc (NASDAQ: SOFI), which reported better-than-expected financial results and raised full-y
FDA Accepts MediWound’s Refiling For Severe Thermal Burns Therapy For Review
The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.